Research programme: breast cancer vaccine - Vaccinex
Latest Information Update: 18 Oct 2012
At a glance
- Originator Vaccinex
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 18 Oct 2012 Discontinued - Preclinical for Breast cancer in USA (Parenteral)
- 24 Sep 2002 Preclinical trials in Breast cancer in USA (unspecified route)